Chuangxing Guo

1.6k citations

29 papers · 1.2k indexed · h-index 19

Co-authors: P. L. Fuchs Thomas Lacour Michael R. Boyd Susan E. Kephart Joseph Marakovits Brion W. Murray Eleanor Dagostino Liming Dong
Topics: Signaling Pathways in Disease (5 papers)Peptidase Inhibition and Analysis (5 papers)Phytochemical Studies and Bioactivities (5 papers)
Cited by: Biotechnology Toxicology Organic Chemistry
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Cancer Research
Partner nations: United States China Canada

In The Last Decade

Chuangxing Guo

29 papers receiving 1.2k citations

Peers

Countries citing papers authored by Chuangxing Guo

Since Specialization

Citations

This map shows the geographic impact of Chuangxing Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuangxing Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuangxing Guo more than expected).

Fields of papers citing papers by Chuangxing Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuangxing Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuangxing Guo. The network helps show where Chuangxing Guo may publish in the future.

Co-authorship network of co-authors of Chuangxing Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chuangxing Guo. A scholar is included among the top collaborators of Chuangxing Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuangxing Guo. Chuangxing Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket 2014 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Xinjun Hou,Liming Dong,Joseph Marakovits,S.E. Greasley,Eleanor Dagostino,Rose Ann Ferre,M. Catherine Johnson,Paul S. Humphries,Haitao Li,Genevieve Paderes,Joseph Piraino,Eugenia Kraynov,Brion W. Murray	38
2	Abstract 614: Proxalutamide (GT0918), a potent androgen receptor pathway inhibitor 2014 ·Cancer Research ·Youzhi Tong,Chunyun Chen,Juan Wu,(unknown),Huihui Zhang,Xiaojun Wu,(unknown),Wei Gao,(unknown),Xiao-Xia Niu,(unknown),Chuangxing Guo	13
3	Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators 2013 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Angelica Linton,Mehran Jalaie,Susan E. Kephart,Martha A. Ornelas,Mason Pairish,S.E. Greasley,Paul Richardson,Karen A. Maegley,Michael J. Hickey,John Li,Xin Wu,Ji X,Zhi Xie	42
4	Abstract 2460: Discovery of potent androgen receptor antagonists for treating CRPC and AR+ breast cancer. 2013 ·Cancer Research ·Youzhi Tong,Chunyun Chen,Juan Wu,Huihui Zhang,Xiaojun Wu,(unknown),Wei Gao,Xiao-Xia Niu,Linglan Ma,Chuangxing Guo	1
5	Structural modifications of a 3-methoxy-2-aminopyridine compound to reduce potential for mutagenicity and time-dependent drug–drug interaction 2012 ·Bioorganic & Medicinal Chemistry Letters ·Cynthia L. Palmer,Mason Pairish,Susan E. Kephart,Djamal Bouzida,Jingrong Jean Cui,Judith G. Deal,Liming Dong,(unknown),Angelica Linton,Indrawan McAlpine,Shinji Yamazaki,Evan Smith,(unknown),Shubha Bagrodia,Robert S. Kania,Chuangxing Guo	3
6	Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Mason Pairish,Angelica Linton,Susan E. Kephart,Martha A. Ornelas,Asako Nagata,Benjamin J. Burke,Liming Dong,(unknown),Andrea Fanjul	20
7	Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer 2011 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Susan E. Kephart,Martha A. Ornelas,Javier González,Angelica Linton,Mason Pairish,Asako Nagata,S.E. Greasley,Jeff Elleraas,Natilie Hosea,(unknown),Andrea Fanjul	11
8	Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO) 2011 ·Journal of Medicinal Chemistry ·Angelica Linton,Ping Kang,Martha A. Ornelas,Susan E. Kephart,Qiyue Hu,Mason Pairish,Ying Jiang,Chuangxing Guo	71
9	An efficient synthesis of highly functionalized chiral lactams 2011 ·Tetrahedron Letters ·Martha A. Ornelas,Javier González,Neal W. Sach,Paul Richardson,Kevin D. Bunker,Angelica Linton,Susan E. Kephart,Mason Pairish,Chuangxing Guo	5
10	Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth 2010 ·Proceedings of the National Academy of Sciences ·Brion W. Murray,Chuangxing Guo,Joseph Piraino,John Westwick,Cathy Zhang,Jane E. Lamerdin,Eleanor Dagostino,(unknown),Cho‐Ming Loi,Michael Zager,Eugenia Kraynov,Ian Popoff,James G. Christensen,(unknown),Susan E. Kephart,Joseph Marakovits,(unknown),Simon Bergqvist,Tod Smeal	253
11	Structure-based design of novel human Pin1 inhibitors (II) 2010 ·Bioorganic & Medicinal Chemistry Letters ·Liming Dong,Joseph Marakovits,Xinjun Hou,Chuangxing Guo,S.E. Greasley,Eleanor Dagostino,Rose Ann Ferre,M. Catherine Johnson,Eugenia Kraynov,James Thomson,(unknown),Brion W. Murray	70
12	An efficient synthesis of sulfamides 2010 ·Tetrahedron Letters ·Chuangxing Guo,Liming Dong,Susan E. Kephart,Xinjun Hou	13
13	Structure-based design of novel human Pin1 inhibitors (I) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Xinjun Hou,Liming Dong,Eleanor Dagostino,S.E. Greasley,Rose Ann Ferre,Joseph Marakovits,M. Catherine Johnson,David A. Matthews,Barbara Mroczkowski,Hans E. Parge,Todd VanArsdale,Ian Popoff,Joseph Piraino,Stephen A. Margosiak,James Thomson,Gerrit Los,Brion W. Murray	91
14	A concise synthesis of AG5473/5507 utilizing N-acyliminium ion chemistry 2000 ·Tetrahedron Letters ·Chuangxing Guo,Siegfried Reich,(unknown),(unknown),Liming Dong	11
15	On the relationship of OSW-1 to the cephalostatins 1999 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Thomas Lacour,P. L. Fuchs	58
16	On topography and functionality in the B-D rings of cephalostatin cytotoxins 1999 ·Bioorganic & Medicinal Chemistry Letters ·Thomas Lacour,Chuangxing Guo,Sunghoon Ma,Jae Uk Jeong,Michael R. Boyd,(unknown),Nobuhiro Fusetani,P. L. Fuchs	21
17	Synthesis of the South Unit of Cephalostatin. 7. Total Syntheses of (+)-Cephalostatin 7, (+)-Cephalostatin 12, and (+)-Ritterazine K¹ 1999 ·Journal of the American Chemical Society ·Jae Uk Jeong,Chuangxing Guo,P. L. Fuchs	48
18	Outer-Ring Stereochemical Modulation of Cytotoxicity in Cephalostatins¹ 1999 ·Organic Letters ·Thomas Lacour,Chuangxing Guo,Michael R. Boyd,P. L. Fuchs	26
19	Interphylal Product Splicing: The First Total Syntheses of Cephalostatin 1, the North Hemisphere of Ritterazine G, and the Highly Active Hybrid Analogue, Ritterostatin G_N1_N¹ 1998 ·Journal of the American Chemical Society ·Thomas Lacour,Chuangxing Guo,(unknown),Michael R. Boyd,P. L. Fuchs	95
20	Photochemistry of Thiarubrine A and Other 1,2-Dithiins: Formation of 2,6-Dithiabicyclo[3.1.0]hex-3-enes 1996 ·Journal of the American Chemical Society ·Eric Block,(unknown),John P. Toscano,(unknown),Xing Zhang,Russell J. DeOrazio,Chuangxing Guo,Robert S. Sheridan,G.H.N. Towers	27

About Chuangxing Guo

Chuangxing Guo is a scholar working on Toxicology, Organic Chemistry and Biotechnology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), Peptidase Inhibition and Analysis (5 papers) and Phytochemical Studies and Bioactivities (5 papers). The work is most often cited by research in Biotechnology (167 citations), Toxicology (51 citations) and Organic Chemistry (363 citations). Chuangxing Guo has collaborated with scholars based in United States, China and Canada. Frequent co-authors include P. L. Fuchs, Thomas Lacour, Michael R. Boyd, Susan E. Kephart, Joseph Marakovits, Brion W. Murray, Eleanor Dagostino, Liming Dong, Eugenia Kraynov and Joseph Piraino. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact